HIF-1 consequently induces tumor secretion of CXCL12, which binds to CXCR4 on proangiogenic bone marrow–derived cells (BMDCs), recruiting them to become endothelial cells within the tumor [23, 24]. The gene discussed is HIF1A; the disease is neoplasm.